Prime Medicine, Inc.PRMEEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| ARCH Venture Fund X, L.P. | 11.80% | 15.5M | ▼ -1.10pp | 2024-11-22 |
| Bristol-Myers Squibb Company | 8.40% | 11.0M | — | 2024-10-04 |
| GV 2019, L.P. | 8.20% | 10.1M | ▼ -2.20pp | 2024-02-29 |
| FMR LLC | 6.44% | 7.7M | ▼ -2.90pp | 2024-11-12 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.